Mounjaro Tablets UK: Injection Form from £124.99

Clinically Proven UK Registered Pharmacy

Mounjaro Tablets - Injection Format from £124.99

Mounjaro available as injection in the UK from £124.99 plus £20 off first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Mounjaro Tablets: Format, Availability, and Treatment Options in the UK

Published: 11 September 2026

Many patients searching for Mounjaro tablets are seeking an oral alternative to the injection format, but it's important to clarify that Mounjaro (tirzepatide) is currently licensed and available in the UK exclusively as a subcutaneous injection, not as a tablet. The confusion often arises from the availability of other GLP-1 medications in oral form, such as Wegovy® Oral Tablets (semaglutide pill). At Cured Pharmacy, our UK-registered clinical team can assess your suitability for Mounjaro injections from £124.99, or discuss alternative tablet options if injections are not suitable for you.

What Are Mounjaro Tablets and Are They Available in the UK?

Mounjaro tablets do not currently exist as a licensed medication in the United Kingdom. Mounjaro is the brand name for tirzepatide, a dual GIP/GLP-1 receptor agonist approved by the MHRA exclusively as a pre-filled injection pen (KwikPen) for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. The injection is administered once weekly subcutaneously, typically in the abdomen, thigh, or upper arm.

While pharmaceutical companies are researching oral formulations of GLP-1 and dual-agonist medications, tirzepatide in tablet form has not yet received regulatory approval in the UK or EU. Patients seeking a tablet alternative to Mounjaro injections may consider Wegovy® Oral Tablets (semaglutide pill), which is a GLP-1 receptor agonist available in oral form and licensed for weight loss in the UK [2]. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and clinical team can guide you through the available options during your free online consultation.

Why Mounjaro Tablets Are Sought After: Understanding Patient Preferences

The demand for Mounjaro tablets stems from common concerns about self-injection. Many patients experience needle anxiety, find weekly injections inconvenient, or prefer the discretion of taking a daily tablet. In our experience at Cured Pharmacy, approximately 30% of initial enquiries about Mounjaro specifically ask whether a tablet version exists, reflecting a genuine patient preference for oral medication.

However, the injection format of Mounjaro offers distinct pharmacokinetic advantages. Subcutaneous tirzepatide achieves predictable bioavailability and sustained therapeutic levels with once-weekly dosing, whereas oral formulations of incretin-based therapies typically require daily administration and specialised absorption enhancers to overcome gastric degradation [3]. The SURPASS clinical trial programme demonstrated that tirzepatide injections produced average weight reductions of 15-22.5% over 72 weeks, depending on dose, with the injection format ensuring consistent drug delivery [1].

Injection Technique and Ease of Use

Modern Mounjaro KwikPens are designed for simplicity, featuring a hidden needle, audible click confirmation, and colour-coded dose selectors. Most patients report that after the first one or two injections, the process becomes routine and takes less than 30 seconds. Our clinical team provides comprehensive injection training materials and ongoing support to ensure confidence and correct technique, subject to prescriber approval.

Mounjaro Tablets vs Injection: Comparing Treatment Formats and Efficacy

Since Mounjaro tablets are not available, patients often compare the existing Mounjaro injection with oral weight-loss medications. Wegovy® Oral Tablets (semaglutide pill) represent the closest licensed alternative, offering a GLP-1 receptor agonist in tablet form. Clinical trials of oral semaglutide for weight management have shown average weight loss of approximately 15% over 68 weeks, comparable to injectable semaglutide but requiring daily dosing rather than weekly [2].

Tirzepatide injections, by contrast, target both GIP and GLP-1 receptors, which may contribute to superior weight loss outcomes in head-to-head trials. The SURPASS-2 trial directly compared tirzepatide 15mg weekly injections to semaglutide 1mg weekly injections, demonstrating significantly greater HbA1c reduction and weight loss with tirzepatide [4]. While no tablet formulation of tirzepatide exists yet, patients seeking oral treatment can access semaglutide tablets at Cured Pharmacy from £124.99, with the same rigorous clinical assessment process.

Frequency and Convenience Considerations

Weekly injections offer the advantage of fewer dosing occasions—52 per year compared to 365 for daily tablets. This can improve adherence and reduce the mental load of daily medication routines. Conversely, daily tablets allow dose flexibility and may be easier to discontinue if side effects occur. Our prescribers will discuss your lifestyle, preferences, and clinical suitability to recommend the most appropriate format during your online consultation.

Treatment Type Frequency Starting Price
Mounjaro (Tirzepatide) Injection Once weekly From £145.00
Wegovy® Oral Tablets Tablet (Semaglutide) Once daily From £83.00
Wegovy Injection Injection (Semaglutide) Once weekly From £89.00
Orlistat Tablet (Lipase Inhibitor) Three times daily From £32.00
Saxenda Injection (Liraglutide) Once daily From £68.00

Mounjaro Tablets Pricing and How to Access Treatment at Cured Pharmacy

At Cured Pharmacy, Mounjaro injections (tirzepatide KwikPen) are available from £124.99 per pack, subject to clinical assessment by a UK-registered prescriber. We guarantee the lowest UK prices and offer £20 off your first order with code Weightlossnew, bringing your initial cost to £124.99. All pricing is transparent and displayed upfront—before you complete your consultation—so there are no hidden fees or surprise charges.

Accessing Mounjaro tablets is not possible as the tablet form does not exist, but obtaining Mounjaro injections at Cured Pharmacy is straightforward. Begin by completing our free online clinical questionnaire, which takes under three minutes. A UK-registered independent prescriber will review your medical history, BMI, weight-loss goals, and any contraindications. If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy (9012511), with discreet next-day delivery available across the UK [5].

Side Effects and Safety of Mounjaro Tablets and Injections

Because Mounjaro tablets are not available, all safety data pertains to the tirzepatide injection. The most common side effects are gastrointestinal: nausea (reported in up to 30% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during dose escalation [1]. These effects are usually mild to moderate and diminish over time as the body adapts to the medication.

Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when used alongside insulin or sulfonylureas). Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1]. Our prescribers conduct thorough risk assessments and provide detailed safety counselling as part of every consultation, ensuring you understand warning signs and when to seek medical attention.

If a tablet formulation of tirzepatide were to become available, it would likely share the same side effect profile, as these are mechanism-based effects related to GLP-1 and GIP receptor activation rather than the route of administration. Oral semaglutide, for example, has a comparable side effect spectrum to injectable semaglutide [2]. Always report any persistent or severe symptoms to your prescriber or GP promptly.

Managing Gastrointestinal Side Effects

To minimise nausea and digestive discomfort, we recommend starting at the lowest dose (2.5mg weekly), eating smaller meals, avoiding high-fat foods, and staying well hydrated. Gradual dose escalation every four weeks allows your body to adjust and reduces the likelihood of discontinuation due to side effects. Our clinical team provides ongoing support and can adjust your treatment plan if needed.

Alternative Tablet Options to Mounjaro Tablets for Weight Loss

While Mounjaro tablets are not available, several effective oral weight-loss medications are licensed and accessible in the UK. Wegovy® Oral Tablets (semaglutide pill) offer a GLP-1 receptor agonist in daily tablet form, providing an evidence-based alternative for patients who prefer not to inject. Orlistat (available as generic, Xenical, Alli, or Orlos) is a lipase inhibitor that reduces dietary fat absorption and is available from £124.99 at Cured Pharmacy [6].

For patients seeking the efficacy of Mounjaro but unable to tolerate injections, Wegovy® Oral Tablets represent the closest pharmacological match, sharing the same active class (GLP-1 agonist) and demonstrating substantial weight loss in clinical trials [2]. Orlistat works via a different mechanism and is typically associated with more modest weight loss (average 5-10% body weight) but may be suitable for patients with lower BMI or specific clinical profiles [6].

Our UK-registered prescribers will assess your BMI, medical history, previous weight-loss attempts, and treatment preferences to recommend the most appropriate option. Whether you choose Mounjaro injections, Wegovy® Oral Tablets, or another licensed medication, all treatments at Cured Pharmacy are subject to the same rigorous clinical assessment and ongoing monitoring to ensure safety and efficacy.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
  2. Knop, F. K., Aroda, V. R., do Vale, R. D., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 402(10403), 705-719. [accessed 11 September 2026]
  3. Buckley, S. T., Bækdal, T. A., Vegge, A., et al. (2018). Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine, 10(467), eaar7047. [accessed 11 September 2026]
  4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. Lancet, 398(10295), 64-77. [accessed 11 September 2026]
  5. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 11 September 2026]
  6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 11 September 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Are Mounjaro tablets available to buy in the UK?
No, Mounjaro tablets are not currently available in the UK. Mounjaro (tirzepatide) is licensed exclusively as a once-weekly injection. Patients seeking a tablet alternative may consider Wegovy® Oral Tablets (semaglutide pill), available from £124.99 at Cured Pharmacy.
Why isn't Mounjaro available in tablet form?
Tirzepatide, the active ingredient in Mounjaro, is a large peptide molecule that is degraded in the stomach, making oral delivery challenging. While research into oral formulations is ongoing, only the injection format is currently MHRA-approved in the UK.
Can I switch from Mounjaro injections to Mounjaro tablets?
Mounjaro tablets do not exist, so switching to a tablet form of tirzepatide is not possible. However, you may switch to Wegovy® Oral Tablets (semaglutide) or another oral weight-loss medication, subject to prescriber approval and clinical assessment.
How effective are Mounjaro injections compared to weight-loss tablets?
Mounjaro injections have demonstrated average weight loss of 15-22.5% in clinical trials, significantly higher than most oral medications. Wegovy® Oral Tablets (semaglutide) achieve approximately 15% average weight loss, while Orlistat typically results in 5-10% weight reduction.
What is the cheapest alternative to Mounjaro tablets in the UK?
Since Mounjaro tablets are not available, the most affordable oral weight-loss medication at Cured Pharmacy is Orlos (Orlistat 60mg) from £124.99. For injectable GLP-1 medications, Saxenda starts from £124.99 and Wegovy from £124.99.
Do I need a prescription for Mounjaro tablets or injections?
Yes, Mounjaro injections are prescription-only medication in the UK and require clinical assessment by a UK-registered prescriber. Cured Pharmacy offers a free online consultation, with approval typically provided within 24 hours, subject to clinical suitability.
How do I take Mounjaro if it's not available as tablets?
Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen. The injection is quick, uses a very fine needle, and can be self-administered at home in the abdomen, thigh, or upper arm after brief training.
Will Mounjaro tablets become available in the future?
Pharmaceutical research into oral formulations of tirzepatide is ongoing, but no timeline for UK approval has been announced. Patients can register interest with Cured Pharmacy to be notified if an oral Mounjaro tablet becomes licensed in the future.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 11 September 2026

Last updated on 11 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 11 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (11 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.